Daily trading records
Drugs Made In America Acquisition Stock Price on September 17, 2026
Direct answer
Drugs Made In America Acquisition closed at $10.84 on September 17, 2026.
Get free Drugs Made In America Acquisition email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Review Drugs Made In America Acquisition's price trend and period performance.
The chart connects verified session closes from June 4, 2026 through September 17, 2026.
Period performance is calculated from verified trading sessions.
5-session performance
+0.37%
From the September 10, 2026 close of $10.80 to $10.84 on September 17, 2026.
20-session performance
+1.12%
From the August 19, 2026 close of $10.72 to $10.84 on September 17, 2026.
60-session performance
+2.17%
From the June 4, 2026 close of $10.61 to $10.84 on September 17, 2026.
Verified data
- Open
- $10.815
- High
- $10.84
- Low
- $10.815
- Close
- $10.84
- Volume
- 921
- Prior-close change
- $0.00 (0.00%)
Explore related company data
Read the frequently asked questions.
What was Drugs Made In America Acquisition's closing price on September 17, 2026?
Drugs Made In America Acquisition closed at $10.84 on September 17, 2026.
What were Drugs Made In America Acquisition's open, high and low on September 17, 2026?
The open was $10.815, the high was $10.84 and the low was $10.815.
How much did Drugs Made In America Acquisition change from the prior close on September 17, 2026?
The change from the prior close was $0.00 (0.00%).
What was Drugs Made In America Acquisition's volume on September 17, 2026?
Trading volume was 921 shares.
What is the source for Drugs Made In America Acquisition's daily prices?
Daily aggregate prices are provided by Polygon.